Welcome to part two of our blog series focused on the integration of diversity, equity, and inclusion (DEI) into clinical research. If you missed part one of the series that highlights recent FDA initiatives and legislative changes behind these developments,...
In the ever-evolving field of global clinical research, the integration of diversity, equity, and inclusion (DEI) has become a pivotal focus, especially considering recent FDA initiatives and legislative changes. The U.S. Food and Drug Administration's (FDA) ongoing efforts, coupled with...
Centralized monitoring's state-of-the-art approaches and tools are reshaping clinical trials' efficiency, accuracy, and overall effectiveness. Here we discuss the core methodologies that underpin centralized monitoring—study-level and patient-level data analysis—and how these strategies collaboratively refine the monitoring process. Moreover, we outline...
In the dynamic arena of clinical trials, optimizing efficiency, maintaining cost-effectiveness, and safeguarding the integrity of collected data are important considerations. Traditional onsite monitoring has long been the cornerstone of ensuring data accuracy and patient safety. However, as technology and...
MORRISVILLE, N.C., August 15, 2023 — Premier Research has strategically expanded its Clinical Development Services team to enhance therapeutic strategy, special patient population expertise, and risk-based clinical development service offerings for biotech and medtech sponsors. “With the patient experience at...
MORRISVILLE, N.C., June 15, 2023 — Premier Research, whose mission is to help the most innovative biotech and medtech companies take their best ideas from concept to commercialization, was honored to be recognized at the 2023 CRO Leadership Awards as...